Literature DB >> 861168

Changes in the concentration of leucocytes and platelets in the peripheral blood during sterile inflammation in rabbits.

L F Ng, M Zuzel, G V Born.   

Abstract

Glycogen in isotonic saline was infused into the peritoneal cavities of rabbits to produce sterile inflammation. This caused a small increase in the haematocrit value and larger decreases in the concentrations of circulation leucocytes and platelets. Circulating granulocytes decreased by about 40% in 2 h and increased in the next 2 h to about 4 times their initial concentration. Acetyl salicyclic acid (ASA) (10 mg/kg) infused with the glycogen did not affect the decrease significantly but accelerated the subsequent increase. Circulating mononuclear leucocytes, mostly lymphocytes, decreased progressively by about 75% after 4-5 h. This decrease was not affected by ASA. Circulating platelets decreased by about 30% in the first hour; this decrease was accelerated and augmented by ASA. Subsequently the platelet concentrations remained constant for at least 4-5 h. Glycogen so infused is known to activate complement, and ASA to inhibit prostaglandin synthetase. Therefore the results suggest that (i) the initial decrease in circulating granulocytes is mediated by activated complement; (ii) the emigration of granulocytes from blood into the inflammatory exudate is increased by prostaglandins; (iii) the initial decrease in circulating platelets is mediated by activated complement and antagonized by prostaglandins; and (iv) the decrease in circulating lymphocytes is mediated by activated complement and uninfluenced by prostaglandins.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 861168      PMCID: PMC2041283     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  11 in total

1.  PLATELET SEQUESTRATION IN MAN. I. METHODS.

Authors:  R H ASTER; J H JANDL
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

2.  The blood volume of normal animals.

Authors:  F C Courtice
Journal:  J Physiol       Date:  1943-12-31       Impact factor: 5.182

3.  Proceedings: Prostaglandin E1 synthesis by phagocytosing rabbit polymorphonuclear leucocytes: its inhibition by indomethacin and its role in chemotaxis.

Authors:  E McCall; L J Youlten
Journal:  J Physiol       Date:  1973-10       Impact factor: 5.182

4.  New biological activity following intravascular activation of the complement cascade.

Authors:  C E McCall; L R De Chatelet; D Brown; P Lachmann
Journal:  Nature       Date:  1974-06-28       Impact factor: 49.962

5.  Relationship between the velocity of rolling granulocytes and that of the blood flow in venules.

Authors:  A Atherton; G V Born
Journal:  J Physiol       Date:  1973-08       Impact factor: 5.182

6.  The adherence of leucocytes and platelets induced by fixed IgG antibody or complement.

Authors:  P M Henson
Journal:  Immunology       Date:  1969-01       Impact factor: 7.397

7.  Quantitative investigations of the adhesiveness of circulating polymorphonuclear leucocytes to blood vessel walls.

Authors:  A Atherton; G V Born
Journal:  J Physiol       Date:  1972-04       Impact factor: 5.182

8.  The initiation of platelet thrombi in normal venules and its acceleration by histamine.

Authors:  N A Begent; G V Born; D E Sharp
Journal:  J Physiol       Date:  1972-05       Impact factor: 5.182

9.  Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates.

Authors:  R Snyderman; J K Phillips; S E Mergenhagen
Journal:  J Exp Med       Date:  1971-11-01       Impact factor: 14.307

10.  A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.

Authors:  C Bianco; R Patrick; V Nussenzweig
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

View more
  1 in total

1.  Animal model of neutropenia suitable for the study of dual-phagocyte systems.

Authors:  S R Rehm; G N Gross; D A Hart; A K Pierce
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.